T080. Rapid Viral Diagnostics for Every Laboratory
Originally Presented: May 27, 2009
Speaker: Christine C. Ginocchio

Summary of Session: This teleconference will review the current methodologies and tests available for the rapid detection of viral infections, including point of care tests, culture methods and molecular based tests. The advantages and disadvantages of each system will be compared. Practical and cost effective testing algorithms will be presented.

Objectives: Upon completion of this Teleconference, participants should be able to:

• Describe the different testing methods available for the rapid detection of viral pathogens;
• Compare the advantages and disadvantages of each method;
• Determine the laboratory techniques most appropriate for their laboratory and patient population; and
• Develop cost effective testing algorithms.

Intended Audience: Medical Technologists, Supervisors, Residents, Fellows, and Laboratory Directors.

CME Disclosures: CME Disclosures: Christine C. Ginocchio, Ph.D. has disclosed financial interests: Diagnostics Hybrids – Clinical Trial Funding 3M – Clinical Trial Funding Luminex Molecular Diagnostics – Scientific Advisory Board

ASM Policy on Faculty Discussion of Unapproved or Unlabeled Uses of Drugs of Devices
In accordance with the ACCME Essential Areas and Policies relating to commercial support, the audience is advised that Dr. Ginocchio will be discussing the following off-label usage of products:

• RVP Assay, identification of viral targets not in FDA cleared version of the assay
• Eragen Respiratory virus panel, not FDA approved
• Diagnostic Hybrids, DFA reagents not FDA cleared

Termination of CME Credit: This program will not be eligible for CME credit after May 27, 2010